SPEDOX-6

N/A

Report date: 2025/10/24 16:19:10

Base Information

Drug NameSPEDOX-6
Drug Alias Namesingle protein encapsulated DOXsingle protein encapsulated doxorubicinProtein-encapsulated doxorubicindoxorubicin encapsulated in a single protein
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSunstate Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of California IrvineSunstate Biosciences LLC
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A